RIGEL PHARMACEUTICALS INC's ticker is and the CUSIP is 766559903. A total of 3 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $236,208 | -14.6% | 159,600 | -16.4% | 0.00% | 0.0% |
Q4 2023 | $276,660 | +51.9% | 190,800 | +13.2% | 0.00% | 0.0% |
Q3 2023 | $182,088 | -19.5% | 168,600 | -3.9% | 0.00% | 0.0% |
Q2 2023 | $226,266 | +54.1% | 175,400 | +57.7% | 0.00% | 0.0% |
Q1 2023 | $146,784 | -27.7% | 111,200 | -17.8% | 0.00% | – |
Q4 2022 | $202,950 | +47.1% | 135,300 | +15.9% | 0.00% | – |
Q3 2022 | $138,000 | -15.3% | 116,700 | -19.2% | 0.00% | – |
Q2 2022 | $163,000 | -49.7% | 144,500 | +33.5% | 0.00% | – |
Q1 2022 | $324,000 | +11.3% | 108,200 | -1.4% | 0.00% | – |
Q4 2021 | $291,000 | -50.0% | 109,700 | -31.6% | 0.00% | -100.0% |
Q3 2021 | $582,000 | +149.8% | 160,400 | +199.3% | 0.00% | – |
Q2 2021 | $233,000 | -48.8% | 53,600 | -59.7% | 0.00% | -100.0% |
Q1 2021 | $455,000 | +0.7% | 132,900 | +2.9% | 0.00% | 0.0% |
Q4 2020 | $452,000 | +191.6% | 129,200 | +100.6% | 0.00% | – |
Q3 2020 | $155,000 | +330.6% | 64,400 | +232.0% | 0.00% | – |
Q2 2020 | $36,000 | +3500.0% | 19,400 | +2325.0% | 0.00% | – |
Q1 2020 | $1,000 | -95.8% | 800 | -93.8% | 0.00% | – |
Q3 2019 | $24,000 | -73.9% | 12,800 | -63.6% | 0.00% | -100.0% |
Q2 2019 | $92,000 | -8.0% | 35,200 | -9.5% | 0.00% | 0.0% |
Q1 2019 | $100,000 | -68.8% | 38,900 | -72.1% | 0.00% | -66.7% |
Q4 2018 | $321,000 | +92.2% | 139,600 | +167.9% | 0.00% | +200.0% |
Q3 2018 | $167,000 | -48.9% | 52,100 | -54.9% | 0.00% | -66.7% |
Q2 2018 | $327,000 | -2.4% | 115,500 | +22.2% | 0.00% | 0.0% |
Q1 2018 | $335,000 | +33.5% | 94,500 | +45.8% | 0.00% | +50.0% |
Q4 2017 | $251,000 | +253.5% | 64,800 | +130.6% | 0.00% | +100.0% |
Q3 2017 | $71,000 | +163.0% | 28,100 | +186.7% | 0.00% | – |
Q2 2017 | $27,000 | -34.1% | 9,800 | -21.6% | 0.00% | – |
Q1 2017 | $41,000 | -76.2% | 12,500 | -82.7% | 0.00% | -100.0% |
Q4 2016 | $172,000 | -59.8% | 72,300 | -38.0% | 0.00% | -60.0% |
Q3 2016 | $428,000 | +14166.7% | 116,700 | +9625.0% | 0.01% | – |
Q2 2016 | $3,000 | -87.0% | 1,200 | -89.1% | 0.00% | – |
Q1 2016 | $23,000 | -57.4% | 11,000 | -38.2% | 0.00% | -100.0% |
Q4 2015 | $54,000 | +500.0% | 17,800 | +394.4% | 0.00% | – |
Q3 2015 | $9,000 | – | 3,600 | +3500.0% | 0.00% | – |
Q2 2015 | $0 | -100.0% | 100 | -99.7% | 0.00% | -100.0% |
Q1 2015 | $140,000 | +122.2% | 39,100 | +124.7% | 0.00% | +100.0% |
Q2 2014 | $63,000 | -35.7% | 17,400 | -31.2% | 0.00% | -50.0% |
Q1 2014 | $98,000 | +164.9% | 25,300 | +96.1% | 0.00% | +100.0% |
Q4 2013 | $37,000 | -55.4% | 12,900 | -44.6% | 0.00% | -50.0% |
Q3 2013 | $83,000 | -30.8% | 23,300 | -35.1% | 0.00% | -33.3% |
Q2 2013 | $120,000 | – | 35,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 50,000 | $112,000 | 0.05% |
SABBY MANAGEMENT, LLC | 1,684 | $375,000 | 0.02% |
GROUP ONE TRADING, L.P. | 1,200 | $3,000 | 0.00% |